FDA’s Biotin Interference Guidance Finalized
Executive Summary
The document recommends testing for blood biotin levels as high as 3500 ng/mL, three times the maximum expected clinical concentration.
You may also be interested in...
Guidance Doc Tackles Biotin Interference In IVDs
Biotin is widely used to encourage skin and hair health. But high biotin levels can interfere with diagnostic tests results, leading the US FDA to issue a draft guidance doc on how manufacturers should address the issue.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
FDA Leader Looks To International Effort On Pediatric Device Development
Collaboration with Japan and Europe could help ease the development path for pediatric devices, cardiovascular device office director Bram Zuckerman said at a recent conference. Zuckerman also spoke on other cardiac device priorities at the FDA.